4 Peripheral T-Cell Lymphoma Clinical Trials in Atlanta, GA (2026)

Q: How do I join a clinical trial in Atlanta?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you.

Recruiting Peripheral T-Cell Lymphoma Studies in Atlanta

NCT05978141Recruiting

A Registry for People With T-cell Lymphoma

The purpose of this registry study is to create a database-a collection of information-for better understanding T-cell lymphoma. Researchers will use the information from this database to learn more a...

Atlanta, GA1,000 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT04803201Recruiting

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

This phase II trial studies the effect of duvelisib or CC-486 and usual chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone in treating patients with perip...

Atlanta, GAPHASE2170 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT06561048Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

A Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in participants with relapse...

Atlanta, GAPHASE3150 participantsCorvus Pharmaceuticals, Inc.

View Study Details

NCT07192471Recruiting

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

The purpose of this study is to determine the safety, tolerability, PK and pharmacodynamics of KK2223 in adult participants with relapsed or refractory peripheral T cell lymphoma (PTCL) or cutaneous T...

Atlanta, GAPHASE172 participantsKyowa Kirin, Inc.

View Study Details

About Peripheral T-Cell Lymphoma Clinical Trials in Atlanta

Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.

There are currently 4 peripheral t-cell lymphoma clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 1,392 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center, Alliance for Clinical Trials in Oncology, Corvus Pharmaceuticals, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Peripheral T-Cell Lymphoma Clinical Trials in Atlanta — FAQ

Are there peripheral t-cell lymphoma clinical trials in Atlanta?

Yes, there are 4 peripheral t-cell lymphoma clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What peripheral t-cell lymphoma treatments are being tested?

The 4 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.

Data updated October 15, 2026 from ClinicalTrials.gov